EMEA (Europe, Middle East and Africa) Antivenom Serum Market Report 2017

August 2017 | 100 pages | ID: EE3BF2EA96AEN
QYResearch

Abstracts

In this report, the EMEA Antivenom Serum market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Antivenom Serum for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Antivenom Serum market competition by top manufacturers/players, with Antivenom Serum sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Summerland Serums (AU)
• Haffkine Bio Pharmaceutical
• MicroPharm
• CSL (AU)
• SAVP
• Flynn Pharma
• Serum

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into

• Humans
• Animals

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Doses), market share and growth rate of Antivenom Serum for each application, including

• Monovalent
• Polyvalent

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Antivenom Serum Market Report 2017

1 ANTIVENOM SERUM OVERVIEW

1.1 Product Overview and Scope of Antivenom Serum
1.2 Classification of Antivenom Serum
  1.2.1 EMEA Antivenom Serum Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Antivenom Serum Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Humans
  1.2.4 Animals
1.3 EMEA Antivenom Serum Market by Application/End Users
  1.3.1 EMEA Antivenom Serum Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Monovalent
  1.3.3 Polyvalent
1.4 EMEA Antivenom Serum Market by Region
  1.4.1 EMEA Antivenom Serum Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Antivenom Serum (2012-2022)
  1.5.1 EMEA Antivenom Serum Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Antivenom Serum Revenue and Growth Rate (2012-2022)

2 EMEA ANTIVENOM SERUM COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Antivenom Serum Market Competition by Players/Manufacturers
  2.1.1 EMEA Antivenom Serum Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Antivenom Serum Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Antivenom Serum Sale Price by Players (2012-2017)
2.2 EMEA Antivenom Serum (Volume and Value) by Type/Product Category
  2.2.1 EMEA Antivenom Serum Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Antivenom Serum Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Antivenom Serum Sale Price by Type (2012-2017)
2.3 EMEA Antivenom Serum (Volume) by Application
2.4 EMEA Antivenom Serum (Volume and Value) by Region
  2.4.1 EMEA Antivenom Serum Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Antivenom Serum Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Antivenom Serum Sales Price by Region (2012-2017)

3 EUROPE ANTIVENOM SERUM (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Antivenom Serum Sales and Value (2012-2017)
  3.1.1 Europe Antivenom Serum Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Antivenom Serum Revenue and Growth Rate (2012-2017)
3.2 Europe Antivenom Serum Sales and Market Share by Type
3.3 Europe Antivenom Serum Sales and Market Share by Application
3.4 Europe Antivenom Serum Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Antivenom Serum Sales Volume by Countries (2012-2017)
  3.4.2 Europe Antivenom Serum Revenue by Countries (2012-2017)
  3.4.3 Germany Antivenom Serum Sales and Growth Rate (2012-2017)
  3.4.4 France Antivenom Serum Sales and Growth Rate (2012-2017)
  3.4.5 UK Antivenom Serum Sales and Growth Rate (2012-2017)
  3.4.6 Russia Antivenom Serum Sales and Growth Rate (2012-2017)
  3.4.7 Italy Antivenom Serum Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Antivenom Serum Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTIVENOM SERUM (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Antivenom Serum Sales and Value (2012-2017)
  4.1.1 Middle East Antivenom Serum Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Antivenom Serum Revenue and Growth Rate (2012-2017)
4.2 Middle East Antivenom Serum Sales and Market Share by Type
4.3 Middle East Antivenom Serum Sales and Market Share by Application
4.4 Middle East Antivenom Serum Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Antivenom Serum Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Antivenom Serum Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Antivenom Serum Sales and Growth Rate (2012-2017)
  4.4.4 Israel Antivenom Serum Sales and Growth Rate (2012-2017)
  4.4.5 UAE Antivenom Serum Sales and Growth Rate (2012-2017)
  4.4.6 Iran Antivenom Serum Sales and Growth Rate (2012-2017)

5 AFRICA ANTIVENOM SERUM (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Antivenom Serum Sales and Value (2012-2017)
  5.1.1 Africa Antivenom Serum Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Antivenom Serum Revenue and Growth Rate (2012-2017)
5.2 Africa Antivenom Serum Sales and Market Share by Type
5.3 Africa Antivenom Serum Sales and Market Share by Application
5.4 Africa Antivenom Serum Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Antivenom Serum Sales Volume by Countries (2012-2017)
  5.4.2 Africa Antivenom Serum Revenue by Countries (2012-2017)
  5.4.3 South Africa Antivenom Serum Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Antivenom Serum Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Antivenom Serum Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Antivenom Serum Sales and Growth Rate (2012-2017)

6 EMEA ANTIVENOM SERUM MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antivenom Serum Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Antivenom Serum Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Summerland Serums (AU)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Antivenom Serum Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Summerland Serums (AU) Antivenom Serum Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Haffkine Bio Pharmaceutical
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Antivenom Serum Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Haffkine Bio Pharmaceutical Antivenom Serum Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 MicroPharm
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Antivenom Serum Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 MicroPharm Antivenom Serum Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CSL (AU)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Antivenom Serum Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CSL (AU) Antivenom Serum Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 SAVP
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Antivenom Serum Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 SAVP Antivenom Serum Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Flynn Pharma
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Antivenom Serum Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Flynn Pharma Antivenom Serum Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Serum
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Antivenom Serum Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Serum Antivenom Serum Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 ANTIVENOM SERUM MANUFACTURING COST ANALYSIS

7.1 Antivenom Serum Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antivenom Serum

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antivenom Serum Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antivenom Serum Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTIVENOM SERUM MARKET FORECAST (2017-2022)

11.1 EMEA Antivenom Serum Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Antivenom Serum Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Antivenom Serum Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Antivenom Serum Price and Trend Forecast (2017-2022)
11.2 EMEA Antivenom Serum Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Antivenom Serum Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Antivenom Serum Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Antivenom Serum Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Antivenom Serum Sales Forecast by Type (2017-2022)
11.7 EMEA Antivenom Serum Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antivenom Serum
Figure EMEA Antivenom Serum Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Antivenom Serum Sales Volume Market Share by Type (Product Category) in 2016
Figure Humans Product Picture
Figure Animals Product Picture
Figure EMEA Antivenom Serum Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Antivenom Serum by Application in 2016
Figure Monovalent Examples
Table Key Downstream Customer in Monovalent
Figure Polyvalent Examples
Table Key Downstream Customer in Polyvalent
Figure EMEA Antivenom Serum Market Size (Million USD) by Region (2012-2022)
Figure Europe Antivenom Serum Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antivenom Serum Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Antivenom Serum Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Antivenom Serum Revenue (Million USD) Status and Forecast by Countries
Figure Africa Antivenom Serum Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Antivenom Serum Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Antivenom Serum Sales Volume and Growth Rate (2012-2022)
Figure EMEA Antivenom Serum Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Antivenom Serum Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Antivenom Serum Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Antivenom Serum Sales Share by Players (2012-2017)
Figure 2016 Antivenom Serum Sales Share by Players
Figure 2017 Antivenom Serum Sales Share by Players
Figure EMEA Antivenom Serum Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Antivenom Serum Revenue (Million USD) by Players (2012-2017)
Table EMEA Antivenom Serum Revenue Share by Players (2012-2017)
Table 2016 EMEA Antivenom Serum Revenue Share by Players
Table 2017 EMEA Antivenom Serum Revenue Share by Players
Table EMEA Antivenom Serum Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Antivenom Serum Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Antivenom Serum Sales Share by Type (2012-2017)
Figure Sales Market Share of Antivenom Serum by Type (2012-2017)
Figure EMEA Antivenom Serum Sales Market Share by Type (2012-2017)
Table EMEA Antivenom Serum Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Antivenom Serum Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antivenom Serum by Type in 2016
Table EMEA Antivenom Serum Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Antivenom Serum Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Antivenom Serum Sales Share by Application (2012-2017)
Figure Sales Market Share of Antivenom Serum by Application (2012-2017)
Figure EMEA Antivenom Serum Sales Market Share by Application in 2016
Table EMEA Antivenom Serum Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Antivenom Serum Sales Share by Region (2012-2017)
Figure Sales Market Share of Antivenom Serum by Region (2012-2017)
Figure EMEA Antivenom Serum Sales Market Share in 2016
Table EMEA Antivenom Serum Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Antivenom Serum Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Antivenom Serum by Region (2012-2017)
Figure EMEA Antivenom Serum Revenue Market Share Regions in 2016
Table EMEA Antivenom Serum Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Antivenom Serum Revenue and Growth Rate (2012-2017)
Table Europe Antivenom Serum Sales (K Doses) by Type (2012-2017)
Table Europe Antivenom Serum Market Share by Type (2012-2017)
Figure Europe Antivenom Serum Market Share by Type in 2016
Table Europe Antivenom Serum Sales (K Doses) by Application (2012-2017)
Table Europe Antivenom Serum Market Share by Application (2012-2017)
Figure Europe Antivenom Serum Market Share by Application in 2016
Table Europe Antivenom Serum Sales (K Doses) by Countries (2012-2017)
Table Europe Antivenom Serum Sales Market Share by Countries (2012-2017)
Figure Europe Antivenom Serum Sales Market Share by Countries (2012-2017)
Figure Europe Antivenom Serum Sales Market Share by Countries in 2016
Table Europe Antivenom Serum Revenue (Million USD) by Countries (2012-2017)
Table Europe Antivenom Serum Revenue Market Share by Countries (2012-2017)
Figure Europe Antivenom Serum Revenue Market Share by Countries (2012-2017)
Figure Europe Antivenom Serum Revenue Market Share by Countries in 2016
Figure Germany Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure France Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Antivenom Serum Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Antivenom Serum Sales (K Doses) by Type (2012-2017)
Table Middle East Antivenom Serum Market Share by Type (2012-2017)
Figure Middle East Antivenom Serum Market Share by Type (2012-2017)
Table Middle East Antivenom Serum Sales (K Doses) by Applications (2012-2017)
Table Middle East Antivenom Serum Market Share by Applications (2012-2017)
Figure Middle East Antivenom Serum Sales Market Share by Application in 2016
Table Middle East Antivenom Serum Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Antivenom Serum Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Antivenom Serum Sales Volume Market Share by Countries in 2016
Table Middle East Antivenom Serum Revenue (Million USD) by Countries (2012-2017)
Table Middle East Antivenom Serum Revenue Market Share by Countries (2012-2017)
Figure Middle East Antivenom Serum Revenue Market Share by Countries (2012-2017)
Figure Middle East Antivenom Serum Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Antivenom Serum Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Antivenom Serum Sales (K Doses) by Type (2012-2017)
Table Africa Antivenom Serum Sales Market Share by Type (2012-2017)
Figure Africa Antivenom Serum Sales Market Share by Type (2012-2017)
Figure Africa Antivenom Serum Sales Market Share by Type in 2016
Table Africa Antivenom Serum Sales (K Doses) by Application (2012-2017)
Table Africa Antivenom Serum Sales Market Share by Application (2012-2017)
Figure Africa Antivenom Serum Sales Market Share by Application (2012-2017)
Table Africa Antivenom Serum Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Antivenom Serum Sales Market Share by Countries (2012-2017)
Figure Africa Antivenom Serum Sales Market Share by Countries (2012-2017)
Figure Africa Antivenom Serum Sales Market Share by Countries in 2016
Table Africa Antivenom Serum Revenue (Million USD) by Countries (2012-2017)
Table Africa Antivenom Serum Revenue Market Share by Countries (2012-2017)
Figure Africa Antivenom Serum Revenue Market Share by Countries (2012-2017)
Figure Africa Antivenom Serum Revenue Market Share by Countries in 2016
Figure South Africa Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Table Merck Antivenom Serum Basic Information List
Table Merck Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merck Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Merck Antivenom Serum Sales Market Share in EMEA (2012-2017)
Figure Merck Antivenom Serum Revenue Market Share in EMEA (2012-2017)
Table Summerland Serums (AU) Antivenom Serum Basic Information List
Table Summerland Serums (AU) Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Summerland Serums (AU) Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Summerland Serums (AU) Antivenom Serum Sales Market Share in EMEA (2012-2017)
Figure Summerland Serums (AU) Antivenom Serum Revenue Market Share in EMEA (2012-2017)
Table Haffkine Bio Pharmaceutical Antivenom Serum Basic Information List
Table Haffkine Bio Pharmaceutical Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Haffkine Bio Pharmaceutical Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Haffkine Bio Pharmaceutical Antivenom Serum Sales Market Share in EMEA (2012-2017)
Figure Haffkine Bio Pharmaceutical Antivenom Serum Revenue Market Share in EMEA (2012-2017)
Table MicroPharm Antivenom Serum Basic Information List
Table MicroPharm Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure MicroPharm Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure MicroPharm Antivenom Serum Sales Market Share in EMEA (2012-2017)
Figure MicroPharm Antivenom Serum Revenue Market Share in EMEA (2012-2017)
Table CSL (AU) Antivenom Serum Basic Information List
Table CSL (AU) Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure CSL (AU) Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure CSL (AU) Antivenom Serum Sales Market Share in EMEA (2012-2017)
Figure CSL (AU) Antivenom Serum Revenue Market Share in EMEA (2012-2017)
Table SAVP Antivenom Serum Basic Information List
Table SAVP Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure SAVP Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure SAVP Antivenom Serum Sales Market Share in EMEA (2012-2017)
Figure SAVP Antivenom Serum Revenue Market Share in EMEA (2012-2017)
Table Flynn Pharma Antivenom Serum Basic Information List
Table Flynn Pharma Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Flynn Pharma Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Flynn Pharma Antivenom Serum Sales Market Share in EMEA (2012-2017)
Figure Flynn Pharma Antivenom Serum Revenue Market Share in EMEA (2012-2017)
Table Serum Antivenom Serum Basic Information List
Table Serum Antivenom Serum Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Serum Antivenom Serum Sales (K Doses) and Growth Rate (2012-2017)
Figure Serum Antivenom Serum Sales Market Share in EMEA (2012-2017)
Figure Serum Antivenom Serum Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antivenom Serum
Figure Manufacturing Process Analysis of Antivenom Serum
Figure Antivenom Serum Industrial Chain Analysis
Table Raw Materials Sources of Antivenom Serum Major Manufacturers in 2016
Table Major Buyers of Antivenom Serum
Table Distributors/Traders List
Figure EMEA Antivenom Serum Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Antivenom Serum Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Antivenom Serum Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Antivenom Serum Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Antivenom Serum Sales Market Share Forecast by Region (2017-2022)
Table EMEA Antivenom Serum Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Antivenom Serum Revenue Market Share Forecast by Region (2017-2022)
Table Europe Antivenom Serum Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Antivenom Serum Sales Market Share Forecast by Countries (2017-2022)
Table Europe Antivenom Serum Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Antivenom Serum Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Antivenom Serum Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Antivenom Serum Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Antivenom Serum Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Antivenom Serum Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Antivenom Serum Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Antivenom Serum Sales Market Share Forecast by Countries (2017-2022)
Table Africa Antivenom Serum Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Antivenom Serum Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Antivenom Serum Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Antivenom Serum Sales Market Share Forecast by Type (2017-2022)
Table EMEA Antivenom Serum Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Antivenom Serum Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources